Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Rating)'s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.74 and traded as low as $0.60. Northwest Biotherapeutics shares last traded at $0.60, with a volume of 902,059 shares.

Northwest Biotherapeutics Trading Down 4.6 %

The firm has a 50-day moving average of $0.67 and a 200 day moving average of $0.74. The stock has a market capitalization of $644.77 million, a price-to-earnings ratio of -5.96 and a beta of -0.03.

Northwest Biotherapeutics Company Profile

(Get Rating)

Northwest Biotherapeutics, Inc is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L.

Featured Stories

• Get a free copy of the StockNews.com research report on Northwest Biotherapeutics (NWBO)
• Dave & Buster's Rebound Could Score for Investors
• Cal-Maine: Is it Time to Chase this Stock Higher?
• The Most Important Warren Buffett Stock for Investors: His Own
• Three Mid Caps Wall Street Sees Doubling Within 12 Months
• It's No Stretch: Lululemon Could Break Out of its Range

Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.